Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials

Fertility and Sterility

Volumn 70, Issue 2, 1998, Pages 246-252

  Hirahara, Fumiki ^a   Andoh, Noriko ^a   Sawai, Kaori ^a   Hirabuki, Tomoo ^a   Uemura, Tsuguo ^a   Minaguchi, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Bromocriptine; Hyperprolactinemia; Prolactin; Recurrent miscarriage

Indexed keywords

BROMOCRIPTINE; PROLACTIN; PROTIRELIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FETUS OUTCOME; HUMAN; HYPERPROLACTINEMIA; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; BROMOCRIPTINE; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYPERPROLACTINEMIA; PREGNANCY; PREGNANCY OUTCOME; RECURRENCE;

EID: 0032146956     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00164-2     Document Type: Article

References (25)

1. 1. Berry CW, Brambati B, Eskes TKAB, Exalto N, Fox H, Geraedts JPM et al. The Euro-team early pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod 1995;10:1516-20.
2. 2. Coulam, CB, Clark DA, Beer AE, Kutteh WH, Silver R, Kwak J, et al. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997;38:57-74.
3. 3. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, et al. Recurrent early miscarriage and polycystic ovaries. Br Med J 1988;297:1027-8.
4. 4. Homburg R, Amar NA, Eshel A, Adams J, Jacobs HS. Influence of luteinizing hormone concentration on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-6.
5. 5. Olive DL. The prevalence and epidemiology of luteal phase deficiency in normal and infertile women. Clin Obstet Gynecol 1991;34:157-66.
6. 6. Serle E, Aplin JD, Li TC, Warren MA, Graham RA, Seif MW, et al. Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril 1994;62:989-96.
7. 7. Coulam CB, Stern JJ. Endocrine factors associated with recurrent spontaneous abortion. Clin Obstet Gynecol 1994;37:730-44.
8. 8. Ando N, Gorai I, Hirabuki T, Onose R, Hirahara F, Minaguchi H. Prolactin disorders in patients with habitual abortion. Acta Obstetricia et Gynaecologica Japon 1992;44:650-6.
9. 9. Hirahara F. The clinical management for recurrent spontaneous abortion [in Japanese]. Acta Obstetricia et Gynaecologica Japon 1996;48: 169-72.
10. 10. Seppala M, Hirvonen E, Ranta T. Hyperprolactinaemia and luteal insufficiency. Lancet 1976;229-30.
11. 11. Uemura T, Asukai K, Okamiya Y, Matsuyama A, Shirasu K, Minaguchi H. Functional relationship of gonadotropin and prolactin in the ovary. In: Mizuno M, Mori H, Taketani Y, editor. Role of prolactin in human reproduction. Basel, Kaeger, 1988;136-47.
12. 12. Katz E, Adashi EY. Hyperprolactinemic disorders. Clin Obstet Gynecol 1990;33:622-39.
13. 13. Reinthaller A, Neunteufel W, Bieglmayer C, Fischl F. The metoclopramide-provocation test for prediction of transient hyperprolactinemia during cycle stimulation. Fertil Steril 1990;53:368-71.
14. 14. Asukai K, Uemura T, Minaguchi H. Occult hyperprolactinemia in infertile women. Fertil Steril 1993;60:423-7.
15. 15. Jordan J, Craig K, Clifton DK, Soules MR. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 1994;62:54-62.
16. 16. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
17. 17. Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation or idiopathic hirsutism. Br Med J 1986;293: 355-9.
18. 18. Reinthaller A, Bieglmayer C, Deutinger J, Csaicsich P. Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment. Fertil Steril 1988;49:432-6.
19. 19. Ben-David M, Schenker JG. Transient hyperprolactinemia: a correctable cause of idiopathic female infertility. J Clin Endocrin Metab 1983;57:442-4.
20. 20. Yamaguchi M, Aono T, Koike K, Nishikawa Y, Ikegami H, Miyake A, et al. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea. Eur J Obstet Gynecol Reprod Biol 1991; 39:187-91.
21. 21. Stray-Pedersen B, Stray-Pedersen S. Recurrent abortion: the role of psychotherapy. In: Beard RW, Sharp F, editor. Early pregnancy loss: Mechanisms and treatment. London, Springer-Verlag, 1988:433-40.
22. 22. Buskila D. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991;26:118-2.
23. 23. Reber PM. Prolactin and immunomodulation. Am J Med 1993;95:637-44.
24. 24. Bryant-Greenwood GD, Yamamoto S. Control of peripheral collagenolysis in the human chorio-decidua. Am J Obstet Gynecol 1995;172: 63-70.
25. 25. Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 1995;162:114-22.